Development of the high effective thrombolytic agents with molecular biological technique
Wu, H.Z.; Li, J.Z.
Zhonghua Nei Ke Za Zhi 32(1): 11-13
1993
ISSN/ISBN: 0578-1426 PMID: 8404311 Document Number: 406440
Document emailed within 1 workday
Related Documents
Putseĭko, E.K.; Chalyĭ, A.K. 1974: Interaction of Mg phthalocyanine with a high-molecular biological medium Biofizika 19(1): 57-63Zhdanov, V.M. 1972: Development of molecular-biological studies in microbiological scientific institutions Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(9): 3-6
Kozajda, A.; Szadkowska-Stańczyk, I. 2009: Activities of the National Information Center for Biological Agents present at workplace and preliminary analysis of data collected by the National Register of Biological Agents Medycyna Pracy 60(4): 327-334
Rotin, D.A. 2012: Clinico-morphological and molecular-biological aspects of cerebral metastases development Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 76(2): 70-76
Mavziutov, A.R.; Mirsaiapova, I.A.; Baĭmiev, A.Kh.; Khasanova, G.F.; Mavziutova, G.A.; Ochilova, R.A. 2011: Development and use of test-systems for molecular-genetic detection of out-of-hospital pneumonia agents Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2011(6): 69-72
Dekhanov, D.V.; Vlaskova, N.V. 2011: The use of modern high-intensity radiation sources for the discovery and identification of the traces in the biological and molecular-genetic expertise Sudebno-Meditsinskaia Ekspertiza 54(6): 44-45
Almoosa, K. 2002: Is thrombolytic therapy effective for pulmonary embolism? American Family Physician 65(6): 1097-1102
Bassand, J.P. 1989: The new thrombolytic agents Annales de Cardiologie et d'Angeiologie 38(7 Part 2): 487-491
Charbonnier, B. 1988: New thrombolytic agents La Revue du Praticien 38(19): 1269-1275
Lablanche, J.M. 1989: Thrombolytic agents La Revue du Praticien 39(3): 259-262
Iaremchuk, A.D.; El'skaia, A.V. 1983: Biological activity of tRNA, aminoacyl-tRNA-synthetases and composition of their high molecular weight complexes in regenerating rat liver Ukrainskii Biokhimicheskii Zhurnal 55(4): 363-367
Charbonnier, B.; Lang, M.; Brochier, M. 1987: New thrombolytic agents in myocardial infarction Archives des Maladies du Coeur et des Vaisseaux 80(12): 1785-1791
Rosa, A.; Gautier, J.C. 1991: Thrombolytic agents in cerebral infarctions Revue Neurologique (Paris) 147(2): 99-110
Urban, P.; Gold, H.K.; Goldberg, S. 1983: Reduction of infarct size with thrombolytic agents Cardiovascular Clinics 14(1): 203-215
Nicolau, J.C. 1989: Use of thrombolytic agents in Brazil (1982-1988) Arquivos Brasileiros de Cardiologia 53(2): 81-83
Baruzzi, A.C.; Andrei, A.M.; Cirenza, C.; Knobel, E. 1996: Acute pulmonary thromboembolism. Physiopathogenesis and use of thrombolytic agents Arquivos Brasileiros de Cardiologia 67(3): 201-207
Schuster, H.P. 1992: Thrombolytic agents in acute myocardial infarct. Consensus Medizinische Klinik 87(2): 83
Reikvam, A. 1996: Use of thrombolytic agents and other drugs in acute myocardial infarction Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(14): 1671-1674
Dobrokhotskiĭ, O.N.; Diatlov, A.I. 2013: Main direction of harmonization of Russian and international requirements on providing of biological safety when handling pathogenic biological agents Gigiena i Sanitariia 2013(5): 40-44
Castaigne, A.; Duval-Moulin, A.M.; Dubois-Randé, J.L.; Merlet, P. 1989: Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction Archives des Maladies du Coeur et des Vaisseaux 82(Special Issue 3): 15-20